Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd > HLBZ and GNS tactics being implemented by HUGE

<< Previous

Bullboard Posts

Next >>

Comment by DavidRosenbergon Mar 14, 2023 11:40am

47 Views

Post# 35337427

RE:RE:HLBZ and GNS tactics being implemented by HUGE

What companies did I compare ? $TGTX who had their MS drug approved by FDA ? What comparison did I do ? All I said was they had a FDA drug approved for MS that was immunomodulatory FSD Pharma had phase 1 approval for lucid MS , where is there a comparison ? FSD didn't get their drug approved yet by FDA

your comments are misleading and biased

<< Previous

Bullboard Posts

Next >>

Rich TV Live’s Stocks to Watch this week (Nov. 15, 2024)